TIM-3 therapy for Alzheimer’s is emerging as a promising avenue in the battle against this debilitating disease.Recent studies have shed light on the role of this immune checkpoint molecule, suggesting that its inhibition could liberate microglia— the brain’s immune cells—allowing them to effectively remove amyloid plaques that are notorious for disrupting cognitive function.
